Sunday 14 December | 20:47:49 Europe / Stockholm
Svenska | English

Emplicure

Attachments

Share price change during the day of this press release (SEK).

Subscription

Calendar

Est. time*
2023-11-28 - 15-6 2023
2023-11-17 - Quarterly Report 2023-Q3
2023-08-29 - Quarterly Report 2023-Q2
2023-06-14 - Ex-date Ordinary Dividend EMPLI 0.00 SEK
2023-06-13 - Annual General meeting
2023-05-12 - Quarterly Report 2023-Q1
2023-05-02 - Extra General Meeting 2023
2023-02-23 - Year-end Report 2022
2022-11-17 - Quarterly Report 2022-Q3
2022-11-14 - Extra General Meeting 2022
2022-08-18 - Quarterly Report 2022-Q2
2022-04-26 - Quarterly Report 2022-Q1
2022-04-07 - Ex-date Ordinary Dividend EMPLI 0.00 SEK
2022-04-06 - Annual General meeting
2022-02-22 - Year-end Report 2021
2021-11-19 - Quarterly Report 2021-Q3
2021-08-20 - Quarterly Report 2021-Q2

Description

CountrySweden
SectorHealth care
IndustryDrugs & Trade
Emplicure develops products based on the combination of already approved active substances and material science in bioceramics, with customized release profiles as a specialty. The parent company focuses on medicines, initially for chronic pain and with properties that prevent them from being abused. Through subsidiaries, consumer products are developed, with oral nicotine as the first product line. The range is aimed at pharmaceutical and consumer niches.

Interested in the company’s key figures?

Analyze the company in Börsdata!

Who owns the company?

Find all ownership data in Holdings!

Emplicure AB's application for delisting approved – last day of trading will be 27 November 2023
2023-11-13 18:21:00

Emplicure AB (publ) (the "Company") has as previously announced applied for delisting of the Company's shares from Nasdaq First North Growth Market.

Nasdaq Stockholm has today approved the Company's application for delisting and decided that the last day of trading shall be 27 November 2023.

As previously announced, the Holding Company has informed Emplicure that, in order to give the remaining shareholders of Emplicure the possibility to divest their shares in Emplicure even after the delisting, the Holding Company intends to offer shareholders to tender their shares to the Holding Company after the last day of trading in Emplicure’s shares on Nasdaq First North Growth Market, against a cash consideration corresponding to the amount that the Holding Company will request that the redemption amount is determined to in the squeeze-out proceedings. Additional information regarding the informal tender offer will be announced in connection with the last day of trading in Emplicure’s shares.

For additional information, please contact

Gisela Sitbon 
Chairman of the board of directors
Tel: +46 702 825 558 
Email: gisela@sitbon.nu

About Us
Emplicure uses patented bioceramic technology to develop innovative and effective products to help consumers and patients live better lives. Our consumer division makes tiny, long-lasting and flavorful nicotine pouches that can be an alternative to smoking. Our pharmaceutical division develops safer and tamper-resistant treatments for pain. The share is listed on Nasdaq First North Growth Market (EMPLI). Read more at www.emplicure.com

Attachments
Emplicure AB's application for delisting approved – last day of trading will be 27 November 2023

Source MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

An email has been sent to the given address. To login please click "Login" in that email to verify your account

Companies

Press releases